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The expression of the canine a 2 and 3 subunit isoenxymes of NA,K-ATPase has been investigated in plasma membranes i olated from dog heart, 
brain and kidney by immunoblotting, employing polyclonal anti rat fusion protein, and enzymological techniques. Western blot analysis revealed 
with purified dog membrane Na,K-ATPase preparations, one immunoreactive signal with rat specific cc3 antisera in cardiac tissues, and two 
immunoreactive signals with rat a, and cc3 antisera in cerebral tissues. These findings suggested the specific expression of a3 polypeptide in dog heart 
(99 kDa), whereas dog brain expressed the a 2 and 3 polypeptides. The stained bands were superimposed. The antibody to rat brain a, fusion protein 
did not cross-react with dog antigens whatever the three tissues tested. Expression of the a,-subunit isoform in dog heart membranes was consistent 
with a high affinity digitoxigenin-sensitive class of Na,K-ATPase (IC,, = 7 + 2 nM). A single component with low affinity to digitoxigenin 
(IC&, = 110 f 10 nM) characterized the a, kidney form. The mixture of a, and a3 isoforms in dog brain exhibited an apparent affinity for digitoxigenin 
(I& = 17 + 5 nM) lower than the heart. The sodium dependences of the high affinity digitoxigenin sites were for the cardiac a,form (& = 10 ? 1.9 
mM) and for the cerebral a2 and a3 mixture (&,, 19.6 ? 4.9 mM). The sensitivities for Na’ of the low affinity sites (a,) were: 6.7 f 1.4 mM, 6.3 f 1.2 
mM and 11.6 + 2.9 mM in heart, brain and kidney respectively. This is the first report of the catalytic characteristics of the a3 subunit isoenzyme 
in canine cardiac plasma membranes. 
Key words: Na,K-ATPase; Isoform; Isoenzyme; Heart; Brain; Kidney; Sodium sensitivity; Ouabain aflinity 
1. Introduction 
Na,K-ATPase is a membrane-bound enzyme that cou- 
ples ATP hydrolysis to the translocation of Na’ and K’ 
ions across the plasma membrane. The enzyme exists as 
a heterodimer consisting of a large catalytic a subunit 
(100 kDa) and a smaller glycosylated a subunit (55 kDa). 
Three alpha (a,, a*, a,) and three beta (f’?,, /Iz, /13) sub- 
units have been identified from cDNA cloning [l]. The 
a, isoform is only expressed in the kidney, whatever the 
species considered whereas in the brain, two other 
isoforms (a, and a,) are concomitantly expressed [2]. 
However, each of them can be expressed separately in 
other tissues uch as a2 in the cardiac and skeletal muscle 
[2], a3 in the pineal gland [3], and macrophages [4]. In the 
heart throughout development, the neonatal a3 isoform 
declines rapidly and is replaced by a, in the adult [S-7]. 
In an opposite way, the adaptative response of the heart 
to pressure overload by hypertrophy consists principally 
of an expression of the neonatal a, isoform [8,9]. Re- 
cently, it has been shown that neonatal and adult ferret 
heart express imultaneously the a3 isoforms and not the 
a, isoforms [lo]. The relationship between the expression 
of isoforms of Na,K-ATPase and species or tissues is still 
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poorly understood. This issue seems to be important 
since we and other recently demonstrated expression of 
the three functional a isoforms in human heart in ap- 
proximately equal amounts [ 11,121. 
The most striking difference observed among the three 
isoforms is in their apparent afhnity for Na’. The 
ouabain-sensitive isoform with a very low sensitivity to 
Na’ found by different investigators in rat brain [ 13-151 
and in rat pineal gland [3] is either the a, isoform or the 
a, isoforms depending on the system of enzyme expres- 
sion. Two biochemically distinct isoforms of the a sub- 
unit (a and a+) have been described in dog heart through 
their inhibition profile with digitalis drugs and their mo- 
bilities on SDS-PAGE [ 171. Since it was immunologically 
demonstrated that the a+ form could contain a mixture 
of a2 and a3 isoforms [2], it is our objective to further 
investigate in dog heart and brain the nature and func- 
tion of these two isoforms. We have used the panel of 
antibodies specific for the three rat a subunit isoforms 
[I81 in Western blot analysis of canine microsomal frac- 
tions from kidney, brain and heart. In these 3 tissues, 
functional differences were investigated in terms of sensi- 
tivity to digitalis and Na’. 
2. Materials and methods 
2.1. Microsomal preparations from canine tissues 
They were obtained from sodium pentobarbital(30 mg/kg) anesthe- 
tized adult mongrel dogs of either sex (3 males and 3 females; 10-15 kg). 
The same rapid isolation procedure [19] (less than 2 h) was applied to 
0014-5793/94/$7.00 0 1994 Federation of European Biochemical Societies. All rights reserved. 
SSDI 0014-5793(94)00550-F 
56 I. Berrebi-Bertrand, J.M. MaixentlFEBS Letters 348 (1994) 5540 
the different tissues to eliminate a possible selective loss of one isofonn 
during purification, except for the first step. The first step used 10 g of 
cardiac ventricles, 5 g of whole brain, 5 g of outer medulla kidney. The 
tissues were minced and homogenized in 10 (cardiac)-20 volumes 
(brain and kidney) of ice-cold buffer containing 20 mM sodium pyro- 
phosphate, 0.1 mM phenylmethane sulfonyl fluoride, 250 mM sucrose, 
80 mM KC1 and 20 mM imidazole-HCl (pH 7.4 at 25°C) with a 
polytron PT.20 (10 s; setting 5) for muscle (5 s; setting 5) for brain and 
kidney. For the three tissues, the homogenates were subfractionated by 
two sequential differential centrifugations at 7,000 x g for 15 min and 
46,000 x g for 30 min. The pellet was resuspended in 100 mM NaCl, 
250 mM sucrose and 30 mM imidazole-HCl pH 7.4 and stored frozen 
in liquid N,. The yields in mg of proteins from homogenates to micro- 
somes (approximately l-2%) were similar for the different issues. Pro- 
tein concentration was determined by the method of Lowry [20]. 
2.2. Microsomal preparations from rat tissues 
The methods for the rat brain membrane preparations were those 
previously described [21]. The specific activities of the Na,K-ATPase 
in those preparations were 90 f 15 pmol P,/mg protein x h. 
2.3. SDS-PAGE and Western blots 
Microsomal preparations from kidney, brain, and cardiac muscles 
were electrophoresed and irnmunoblotted with polyclonal antisera. The 
samples were reduced with 20 mM dithiotreitol and solubilized by SDS 
(2%). 
The samples (from 10 to 60 pg) were resolved in a 612% linear 
polyacrylamide gradient. After SDS-PAGE, the proteins were electro- 
phoretically transferred to nitrocellulose sheets at 100 V for 90 min in 
25 mM Tris, 192 mM glycine, 20% methanol according to the method 
described previously 1221. Saturation of the blot was performed by 
incubation overnight at 4°C in phosphate-buffered saline (PBS): 
0.1 M Na-Phosphate, 0.5 M NaCl pH 7.4, containing 3% fat-free milk. 
The nitrocellulose sheets were incubated for 2 h at 37°C with ccl, 2 and 
3 anti-Na,K-ATPase antisera. Blots were incubated with biotinylated- 
donkey anti-rabbit IgG (dil. l/400) (Amersham) washed three fold with 
the PBS fat-free milk 3% then followed by horseradish peroxydase 
conjugated to streptavidin (dil. l/1000) (Amersham) followed by 2 
washings with TBS (0.5 M NaCl 20 mM, Tris-HCl pH 7.5). Specific 
interactions were detected with treatment with 15 mg of 4-chloro-l- 
naphtol (Bio-Rad) dissolved in 5 ml of ice-cold methanol and added to 
25 mg of TBS containing 0.002% hydrogen peroxide. Peroxidase activ- 
ity was stopped by acetic acid 1% (v/v). Specific antisera were purchased 
from Upstate Biotechnology Inc., (New-York), anti-rat Na,K-ATPase 
a,, lot no. 10452; anti-a,, lot no. 10453; anti-a,, lot no. 10454. A 
monoclonal antibody specific for a, isoform was kindly provided by 
Kathleen Sweadner (Harvard University, Cambridge, MA). 
2.4. Enzyme assays 
The enzymatic assays were performed with vesicles treated with SDS 
(0.2-0.3 mg/mg of protein for 30 min at 20°C). 
The Na,K-ATPase activity was measured at 37°C in an ATP regen- 
erating medium by continuously recording NADH oxidation with a 
coupled assay method using a Beckman DU70 spectrophotometer 
[17,i9]. Each-cell contained-100 mM NaCl, 2 mhi phosihoenolpy- 
ruvate. 10 mM KCI. 4 mM ATP. 4 mM MeCl,. 30 mM imidazole-HCl 
(pH 7.& 0.4 mM NADH, 3.5 ‘units py&a& kinase and 5 units of 
lactate dehydrogenase. The enzymatic reaction was initiated by the 
addition from 0.5 to 5 pg of protein. The Na,K-ATPase activity was 
defined as the activity inhibitable by 0.5 mM ouabain or digitoxigenin. 
When the decrease in absorbance was linear versus time, this indicated 
that a new steady-state l vel between drugs and Na,K-ATPase had been 
reached. The specific activities of the Na,K-ATPase were respectively 
28 + 9,70 f 13 and 65 f 12pmol PJmg protein x h for dog heart, brain 
and kidney microsomes. Inhibition percentages were calculated by 
comparing the activities in the presence or absence of digitoxigenin after 
correcting for the ouabain-insensitive ATPase activity. The experimen- 
tal data were fitted using ENZFITTER (Biosoft, Elsevier). The follow- 
ing model was used: 
v = v&&/(Ic~o + C) (1) 
where V is the observed velocity at a given inhibitor concentration (C) 
and V,, is the maximal velocity of the Na,K-ATPase. The best-fit 
curve was calculated using non-linear regression. The experimental 
data were also fitted with one or a sum of two functions assuming the 
presence of one or two sites [19]. Na’-dependent ATPase activities were 
assayed with the same microsomal fractions. Modifications in the assay 
medium were introduced to decrease the Na+ to 0.6 mM. K’ salts of 
the phosphoenolpyruvate and NADH were used instead of Na’ salts. 
The pH was adjusted to pH 7.4 with KOH. 
Na+-dependent ATPase activity was taken as the difference in activ- 
ity in the absence and presence of 0.5 mM ouabain. Assays were per- 
formed in the absence and presence of 100 nM and 0.05 mM digitoxi- 
genin to rapidly inactivate the high and low affinity isozymes, respec- 
tively. The curves were calculated using an equation derived from 
Michaelis-Menten kinetics with a model of highly cooperative sites 
(Equation 2). 
A = A,,, [Na’]‘/(K + ma’]‘) (2) 
where A was the activity at various concentrations of Na+, A,, was the 
maximal value of A. The &,,, i.e. the substrate concentration at which 
the Na,K-ATPase activity was half maximal, could easily be calculated 
from the value of K in Equation 2 as K,,, = a. 
3. Results 
3.1. Localization of the Na,K-ATPase a* and 3 isoforms 
in dog tissues 
Fusion protein antisera to a,, a, and a, were used to 
analyze by immunoblotting the corresponding polypep- 
tide expression in microsomes prepared from adult dog 
heart. The a3 fusion protein antiserum stained a single 
polypeptide band of 99 kDa (apparent molecular mass) 
in dog heart and brain whereas the antiserum a2 reacts 
with a polypeptide of 99 kDa only in dog brain (Fig. 1). 
With the antisera used, no a, subunit was detectable in 
the different dog membrane preparations whatever the 
amount of protein used (from 10 to 60 pug) (data not 
shown). The two polyclonal anti-rat brain aZ and a, 
fusion proteins were specific only for the a, and a, bands 
with apparent molecular weights around 100 kDa, since 
we did not observe any staining of other protein with anti 
aZ and 3 on the blots. We verified the specicifity of the 
a, antisera by demonstrating that this antibody does not 
recognize the canine cl, isoform present in skeletal muscle 
(data not shown). Another a,-specific monoclonal anti- 
body, McB2*, showing specificity for the aZ canine cere- 
bral isoforms did not react with the a+ isoform of dog 
heart (data not shown). These results indicate that a, 
subunit isoform is expressed in dog heart muscles, and 
a2 and a, subunits coexist in brain. These isoforms are 
expressed in a tissue-specific fashion. 
3.2. Enzymatic properties of the cl, and a, subunits 
isoenzymes (comparison to a, kidney form) 
We took advantage of the predominance of a, in the 
kidney and a3 in the heart to compare the functional 
properties of Na,K-ATPase isoenzymes. 
*McB2 is a monoclonal antibody specific for a2 with broad species 
cross-reactivity. 












Fig. 1. Expression of Na,K-ATPase a subunits in dog cardiac micro- 
somes. Solubilized microsomal proteins were fractionated by electro- 
phoresis through an SDS-containing 6-12% polyacrylamide gel, then 
transferred to a nitrocellulose filter and probed with the rat a subunit 
specific antisera indicated on the right. The positions of the molecular 
mass markers are indicated on the left. Rat brain and kidney micro- 
somes were run in control lanes. The identification of the lines are: R,, 
rat kidney; R,, rat brain; D,, dog heart; D,, dog brain and D,, dog 
kidney. 
3.3. Sensitivity to digitoxigenin 
We compared digitoxigenin-sensitive Na,K-ATPase 
activity in microsomal membrane fractions from dog 
heart, brain and kidney. 
The results normalized in percent of Na,K-ATPase 
activity for each membrane fraction and fitted by least 
squares analysis (Equation 1) are presented in Fig. 2. 
Microsomes from dog kidney exhibited, whatever the 
one to three-site model, a single component of digitoxi- 
genin-sensitive Na,K-ATPase activity with a contribu- 
tion of 90% of the total activity. IC,, was 0.10 k 0.01 
PM. 
Data obtained from dog cerebral and cardiac micro- 
somes were best-fitted by a two-site model (IC50 
I = 17 f 5 nM and ICJI = 1.3 f 0.5 ,uM), and 
(ICJ = 7 f 2 nM and ICJI = 0.63 _+ 0.17 PM), respec- 
tively, suggesting at least two components of ouabain 
sensitive Na,K-ATPase activity. This profile was found 
similar for heart and aorta. A three-site model described 
and used for the rat brain membrane data analyses [23- 
25] was unsuccessful in discriminating the cerebral a 2 
or 3 isoforms (data not shown). 
3.4. Na + affinity 
To ascertain whether there are other changes in the 
pump characteristics, a kinetic study was performed to 
estimate the apparent affinity of the Na,K-ATPase for 
Na’. The requirement of isoenzyme was determined by 
measuring ATPase activity at a constant K’ (20 mM) 
and varying Na’ (0.6-100 mM) concentrations. To dis- 
tinguish between the two a forms of the Na,K-ATPase, 
two different concentrations of digitoxigenin have been 
chosen [24,25] and (see Fig. 2); a low concentration (100 
nM) which inhibits almost all the high affinity sites 
(93%), and a few percent of the low affinity sites; a high 
digitalis concentrations (50 ,uM) inhibits the whole activ- 
ity. By difference between the two digitoxigenin concen- 
trations, this activity principally yielded the a, subunit. 
The discrimination by digitoxigenin reveals a different 
pattern of Na+ affinity for heart and brain (Fig. 3 and 
Table 1). In heart, two Na’ affinities of 6.7 and 10 mM 
were attributed to the a, and a3 subunits. For brain 
enzymes which contain in addition to the a, and ~1, car- 
diac subunits the a, isoform, the high affinity inhibitory 
sites to digitoxigenin (the a2 and a, subunits) exhibits a 
K,,5 for Na’ comprised between 15-25 mM, and a & 
around 6 mM for the low amity sites to digitoxigenin. 
4. Discussion 
We took advantage of antisera specific for the a 2 and 
a3 subunits of the Na,K-ATPase to identify for the first 
100 ----__* 
“,I \:‘\, 
f \ \ ppy\;&@ 
09001 0.010 0.100 1.000 10.000 
[DIGITOXIGENIN] (PM) 
Fig. 2. Na,K-ATPase inhibition by digitoxigenin in microsomal mem- 
branes from dog brain, heart, aorta and kidney. Data are expressed as 
percent of total Na,K-ATPase activity relative to V_. The Vm,, are 
respectively 28 f 9, 70 f 13 and 65 f 12 pmol Pi x mg-’ protein x h-’ 
for dog heart, brain and kidney preparations. All, Na,K-ATPases were 
normalized to V,,, of the 0.5 mM ouabain-sensitive activity. Parame- 
ters were estimated by using Equation 1 (section 2). These plots repre- 
sent one experiment, each repeated at least three times with comparable 
results with three separate membrane preparations. For heart and 
brain, the curves represent he best fit of the data obtained from a 
two-site model whereas a one-site model was used for kidney. The IC,, 
values are listed in Table 1. Brain (B) is denoted by -o-; heart (H) by 
o; kidney (K) by A; Aorta (A) by o. 
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Fig. 3. Sodium dependencies of Na,K-ATPase activity in microsomal membranes from dog heart and brain The rate of ouabain inhibitable was 
measured at 37°C using the enzyme-coupled spectrophotometric assay. (A) Brain: (-•-), ATPase activity is expressed as percent of maximal activities 
measured in the presence of 100 nM digitoxigenin; and (-w), ATPase activity between 100 nM and 50 PM digitoxigenin. (B) Heart: (-o)-, measured 
in the presence of 100 nM digitoxigenin; and (-•-) measured between 100 nM and 50 PM digitoxigenin. Symbols are normalized values from three 
separate experiments. Two separate membrane preparations were assayed. Parameters (presented in Table 1) were estimated by using Equation 2 
(section 2). The curves represent the best fit of the data to a model of highly cooperative sites. 
time in dog heart membranes the presence of a single 
immunoreactivity with the antisera specific for a3. Fur- 
thermore there is evidence for a tissue heart (vs. brain) 
specific pattern of expression of the isoforms. 
It is possible that anti a3 and anti a, antibodies raised 
against one rat form (a 2 or 3) crossreact, to some extent, 
with the two dog antigens. We can rule out this hypoth- 
esis, since we demonstrated that these antibodies always 
react against one polypeptide (Fig. 1). Furthermore in 
dog, the a2 presence in smooth muscles has been identi- 
fied with the rat antibodies [26]. 
Another possibility would be that the antibodies spe- 
cific for rat a, subunit lose their specificity for this sub- 
unit isotype in the dog. This leads to a characterization 
of the dog a, subunit both in the presence of a3 and a2 
subunit specific antisera. In this study, it cannot be ex- 
cluded on the basis of a different molecular weight like 
in rat brain, since a very similar apparent molecular 
weight of 98-99 kDa was found. However, in dog brain 
this seems unlikely since monoclonal a, antibody and 
anti-a, specific antibodies derived from rat cloned fusion 
proteins has been found to only cross react with a, sub- 
units in bovines [27] and humans [28]. Besides the proved 
existence of a, isoform with the Northern blot criteria is 
not confined to rat brain or nerves since a, mRNA has 
been clearly demonstrated in the human heart [29,30]. 
More recently in the ferret heart, the peptide mapping of 
the a, immunological signals has been shown to corre- 
spond to the a3 and not to the a, subunit [lo]. An un- 
ambiguous and direct proof in dog will be provided by 
peptide mapping analysis of a, and a3 polypeptides after 
electrophoresis, and by Northern blot analysis with the 
a3 subunit cDNA fragments used as probes. 
The presence of a3 subunit polypeptides might result 
from contaminations of our membranes by nerve mem- 
branes or conducting tissues containing significant 
amounts of the a, subunit [2,31]. This possibility should 
be excluded because predominant source of proteins in 
Table 1 
Sodium and digitoxigenin affinities of a,, a2 and a3 in canine brain, heart and kidney membranes 
Digitoxigenin 
Tissue a subunit isoform V,,,., (%) IGo (nW IGo Wf) 






a,, -, a, 67 7f 2 0.63 ? 0.17 10.0 f 1.9 6.7 f 1.4 
aI, a,, a3 68 17+ 5 1.3 f0.5 19.6 f 4.9* 6.3 f 1.2 
a,, 100 110 + 10 _ 11.6 f 2.9 _ -, - 
All data were analyzed by the non-linear least squares procedures. The IC,, and V,, result from the analysis with a two-site model for heart and 
brain and a one-site model for kidney. I& values are the best-fit of the curves (presented in Fig. 3) according to a model with 3 non-interacting Na’ 
ions required for activity. H.A. (high affinity) and L.A. (low affinity) were defined by the Na,K-ATPase activity inhibited at 100 nM digitoxigenin 
and 50 PM ouabain respectively. 
“Digitoxigenin inhibitable activity of mixture of cz2 and a, subunits. 
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our membranes are provided by cardiac cells far more 
abundant by their volume than the other cell type. In 
addition, we have already demonstrated that cardiomy- 
ocytes isolation without contamination by nerve cells 
prior to membrane purification does not show a differ- 
ence in the electrophoretic pattern at the level of the a 
subunit doublet of the Na,K-ATPase to the purified 
membranes from the whole heart [17]. 
On the other hand, we show that there is no cross 
reactivity between rat specific a, antibodies and dog in 
three tissues tested: heart, brain and kidney. This would 
mean that the epitope constituted by the rat a, subunit 
might present a species pecificity. This has already been 
evidenced for other antibodies specific for rat a, subunit 
PSOI. 
Recent studies have demonstrated substantial differ- 
ences in the functions of a, and CI~ isoforms. Immuno- 
chemical demonstration of a, subunit of Na,K-ATPase 
in dog heart is consistent with previous studies that de- 
scribed the expression of high affinity ouabain-sensitive 
class of Na,K-ATPase. If isoforms in each tissue possess 
the same substrate and inhibitor dependence properties, 
it is tempting to speculate about the relationship of 
isoforms to the enzymatic properties. The comparison of 
the IC,, and contributions between brain, heart and kid- 
ney, reveals differences that suggest hat the dog brain 
cl2 isoenzyme, although not discriminated by a three site 
model, present a lower digitoxigenin sensitivity than the 
CQ high afXnity component of ouabain-sensitive Na,K- 
ATPase activity present in dog heart. This is in agree- 
ment with ouabain-binding studies done in rat brain and 
heart membranes [32]. 
Concerning the Na+ affinity, it is often reported in the 
literature that the Na,K-ATPase from mammalian kid- 
ney (01~) had a lower affinity than the enzyme from nerv- 
ous tissues (a, and cc3 isoforms) [13,33,34]. Because the 
cerebral enzymes are constituted of two a, and a, entities 
in rat, the discrimination of the two subtypes a2 and a3 
and their comparison with the a, kidney form show sim- 
ilar and opposite results to previous reports. A lower [ 151 
or a higher [ 161 affinity to Na’ for a3 than a, has been 
observed. Our results partially confirm that the a, 
isoform confers a lower Na’ affinity than 01, as described 
in the first studies. 
Our comparison of the low-affinity inhibitory sites for 
digitalis between organs shows an heterogeneity between 
the tissues tested, kidney, brain and heart (Table 1). This 
indicates that parameters may have a large influence on 
the apparent affinity for sodium. Some of them (a-a 
composition) have been extensively discussed [ 151. Para- 
meters other than the a subunit such as cc/? complexes, 
environment of the pump [25,35] may have a large influ- 
ence on the apparent affinity for sodium. One of these 
is the presence of two possible complexes a& or a& in 
heart since the /?* protein was detected in our canine 
preparations (J.M.M., unpublished observation). So to 
relate this observed difference of Na+ affinities with a 
subunits, we must practise some caution. One important 
factor is the variation of the apparent affinity with the 
ionic sidedness of distribution of Na’ and K’ found in 
cells. Our experiments with membranes were done with- 
out a membrane potential, under constant ATP, Na+ and 
K’ concentrations. Identical concentrations of each ion 
were present on both sides of the membranes. 
Various combinations of Na’ and K’ concentrations 
that maintain a total concentration of 150 mM shifted 
the apparent affinity to higher values for the three 
isoforms (kidney a,, 46 mM; brain a, + a,, 25 mM; and 
heart a, + a,, 40 mM) [13]. Indeed, in vitro we observed 
that differences could be due to the conditions necessary 
for the enzymatic assay. For example, the replacement 
of imidazole by HEPES desensitized the enzyme to Na’ 
ions (data not shown). On the other hand, the addition 
of choline chloride to maintain the iso-osmolarity with 
dog brain membranes modified the shape and shifted to 
the left the Na’ sensitivity curves. This can be explained 
by a sodium-like effects of imidazole and choline chlo- 
ride as described by Robinson [36]. 
The physiological relevance of the substrate difference 
and distinct distribution of a subunits in dog tissues 
reinforce those reviewed in [37]. The a, form of high 
affinity for sodium (6 mM) will pump under physiologi- 
cal condition near its &,5 value where maximum changes 
in activity can be achieved by a minimal intracellular 
change. In heart, therapeutic oncentrations of digitalis 
produce their inotropic effects through an enhanced so- 
dium transient and a limited myocardial Na’ accumula- 
tion (0.3 mM), whereas toxic concentrations of digitalis 
lead to at least a ten-fold higher Na’ accumulation than 
inotropic doses. Activity of the Na pump is first deter- 
mined by (Na’),, the Na pump isozymes may be differen- 
tially and early activated during each cycle of myocardial 
function [38]. The a3 form of the enzyme would be max- 
imally active only when beneath the membranes the so- 
dium reaches its maximum following the depolarisation 
phase. It will be of interest o characterize directly, in the 
whole cardiomyocyte with intact ionic gradients, the 
functional relevance of the Na,K-ATPase a-isoforms. 
Some other physiological relevance of a2 and a3 protein 
expression in cardiac function can be inferred by the 
analogy with the fact that the switch between 7 and 15 
days after birth is synchronous with the shortening of 
heart- action potential duration in rat [l] and age-related 
changes in electromechanical properties such as the 
higher digitalis tolerance in neonatal dogs as compared 
with adult dogs [39]. Thus, the a3 expression in dog might 
be synchronous with a slow action potential. In heart, 
the a, form has a K,,, for sodium of 6 mM, which means 
that it participated in sodium extrusion under physiolog- 
ical conditions (Na,: 7 mM). The a3 on the other hand 
will be maximally active when (Na’). reaches its maxi- 
mum following the depolarisation phase. This could ex- 
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plain the biphasic increase in (Na+), after addition of 
1 nM to 100 ,uM ouabain to isolated chicken myocytes 
[40] and an enhanced sodium transient and a limited 
myocardial Na’ accumulation resulting from a3 inhibi- 
tion during the positive inotropic effects of digitalis [ 181. 
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